Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Hypertension (Dallas, Tex. : 1979)|June 8, 2002
Conserved synteny in rat and mouse for a blood pressure QTL on human chromosome 17Heike Zimdahl, Thomas Kreitler, Claudia Gösele, et al.
Hypertension (Dallas, Tex. : 1979)|March 19, 2003
The role of Wnk4 in polygenic hypertension: a candidate gene analysis on rat chromosome 10Jan Monti, Heike Zimdahl, Herbert Schulz, et al.
British Journal of Clinical Pharmacology|July 6, 2016
First-in-human study assessing safety, tolerability and pharmacokinetics of BI 409306, a selective phosphodiesterase 9A inhibitor, in healthy malesViktoria Moschetti, Katja Boland, Ulrich Feifel, et al.
Biochemical and Biophysical Research Communications|October 12, 2004
Effect of Add1 gene transfer on blood pressure in reciprocal congenic strains of Milan ratsGrazia Tripodi, Monica Florio, Mara Ferrandi, et al.
Human Psychopharmacology|January 26, 2017
A phase I, randomized, proof-of-clinical-mechanism study assessing the pharmacokinetics and pharmacodynamics of the oral PDE9A inhibitor BI 409306 in healthy male volunteersKatja Boland, Viktoria Moschetti, Chantaratsamon Dansirikul, et al.
Diabetologia|June 8, 2014
Influence of TCF7L2 gene variants on the therapeutic response to the dipeptidylpeptidase-4 inhibitor linagliptinHeike Zimdahl, Carina Ittrich, Ulrike Graefe-Mody, et al.
Plos One|March 2, 2016
Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy PatientsDenis Delić, Claudia Eisele, Ramona Schmid, et al.
Pharmacogenetics and Genomics|August 24, 2011
Integration of absorption, distribution, metabolism, and elimination genotyping data into a population pharmacokinetic analysis of nevirapineThorsten Lehr, Jing Yuan, David Hall, et al.
Pharmacogenetics and Genomics|January 31, 2017
Influence of common polymorphisms in the SLC5A2 gene on metabolic traits in subjects at increased risk of diabetes and on response to empagliflozin treatment in patients with diabetesHeike Zimdahl, Axel Haupt, Michael Brendel, et al.
Molecular Metabolism|April 20, 2021
Challenges in tackling energy expenditure as obesity therapy: From preclinical models to clinical applicationMona C Löffler, Matthias J Betz, Denis P Blondin, et al.
Pageof 2